Medical cost (NT$) during index admission among patients with hip fractures in the non-DM, OAD and insulin cohorts
| Mean (SD) | Model I | Model II | |||
| β (95% CI) | P value | β (95% CI) | P value | ||
| Non-DM cohort | 74 865.2 (47 220.2) | Ref | |||
| OAD cohort | 75 825.1 (53 618.9) | 1038.6 (−1684.8 to 3762.1) | 0.455 | Ref | |
| Insulin cohort | 91 721.8 (89 961.0) | 7927.5 (5021.4 to 10 833.7) | <0.001 | 14 996.34 (8508.0 to 117 750.5) | <0.001 |
Adjusted for age, sex, payroll bracket table, anesthesia type, and Charlson Comorbidity Index score.
Model I: comparison among the non-DM (ref), OAD, and insulin cohorts.
Model II: comparison between the OAD (ref) and insulin cohorts.
DM, diabetes mellitus; NT, New Taiwan; OAD, oral antidiabetic drug; ref, reference.